| __timestamp | Arrowhead Pharmaceuticals, Inc. | HUTCHMED (China) Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 175000 | 19764000 |
| Thursday, January 1, 2015 | 382000 | 67426000 |
| Friday, January 1, 2016 | 158333 | 59752000 |
| Sunday, January 1, 2017 | 31407709 | 65383000 |
| Monday, January 1, 2018 | 16142321 | 70165000 |
| Tuesday, January 1, 2019 | 168795577 | 44738000 |
| Wednesday, January 1, 2020 | 87992066 | 39457000 |
| Friday, January 1, 2021 | 138287000 | 97894000 |
| Saturday, January 1, 2022 | 232810000 | 115306000 |
| Sunday, January 1, 2023 | 240735000 | 453552000 |
| Monday, January 1, 2024 | 3551000 |
Unveiling the hidden dimensions of data
In the dynamic world of biotechnology, HUTCHMED (China) Limited and Arrowhead Pharmaceuticals, Inc. have carved distinct paths. Over the past decade, HUTCHMED has consistently demonstrated robust growth, with its gross profit peaking at an impressive $453 million in 2023, marking a staggering 1300% increase since 2014. This growth underscores HUTCHMED's strategic advancements in the Chinese pharmaceutical market.
Conversely, Arrowhead Pharmaceuticals has shown a more volatile trajectory. Despite a modest start in 2014, Arrowhead's gross profit surged to $241 million by 2023, reflecting a remarkable 137,000% growth. This leap highlights Arrowhead's innovative strides in RNA interference therapeutics.
While both companies have faced challenges, including missing data in recent years, their financial narratives reveal the resilience and potential of biotech firms in shaping the future of medicine.
Regeneron Pharmaceuticals, Inc. vs Arrowhead Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Takeda Pharmaceutical Company Limited vs HUTCHMED (China) Limited
Gross Profit Comparison: Genmab A/S and Arrowhead Pharmaceuticals, Inc. Trends
Gross Profit Trends Compared: Incyte Corporation vs HUTCHMED (China) Limited
Viatris Inc. vs HUTCHMED (China) Limited: A Gross Profit Performance Breakdown
Gross Profit Trends Compared: Catalent, Inc. vs Arrowhead Pharmaceuticals, Inc.
Key Insights on Gross Profit: Pharming Group N.V. vs Arrowhead Pharmaceuticals, Inc.
Gross Profit Comparison: Pharming Group N.V. and HUTCHMED (China) Limited Trends
Gross Profit Trends Compared: Corcept Therapeutics Incorporated vs HUTCHMED (China) Limited
HUTCHMED (China) Limited and Supernus Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
HUTCHMED (China) Limited vs Taro Pharmaceutical Industries Ltd.: A Gross Profit Performance Breakdown
HUTCHMED (China) Limited and Travere Therapeutics, Inc.: A Detailed Gross Profit Analysis